New York-based Tonix Pharmaceuticals Holding Corp. appointed Adeoye Olukotun to its board.
He succeeds Ernest Mario, who stepped down as a director.
Olukotun is CEO of CR Strategies LLC, a clinical research and development consulting firm. His previous roles include CEO of EpiGen Pharmaceuticals Inc. and former vice chairman and CEO of CardioVax Inc.
Tonix Pharmaceuticals has two therapeutic programs focused on post-traumatic stress disorder.